Literature DB >> 31673933

Population-Based Osteoporosis Primary Prevention and Screening for Quality of Care in Osteoporosis, Current Osteoporosis Reports.

William D Leslie1, Carolyn J Crandall2.   

Abstract

PURPOSE OF REVIEW: Despite the high prevalence and impact of osteoporosis, screening and treatment rates remain low, with few women age 65 years and older utilizing osteoporosis screening for primary prevention. RECENT
FINDINGS: This review examines opportunities and challenges related to primary prevention and screening for osteoporosis at the population level. Strategies on how to identify individuals at high fracture risk and target them for treatment have lagged far behind other developments in the osteoporosis field. Most osteoporosis quality improvement strategies have focused on patients with recent or prior fracture (secondary prevention), with limited attention to individuals without prior fracture. For populations without prior fracture, the only quality improvement strategy for which meta-analysis demonstrated significant improvement in osteoporosis care was patient self-scheduling of DXA plus education Much more work is needed to develop and validate effective primary screening and prevention strategies and translate these into high-quality guidelines.

Entities:  

Keywords:  Dual-energy X-ray absorptiometry; Fracture; Osteoporosis; Primary prevention; Screening

Mesh:

Year:  2019        PMID: 31673933     DOI: 10.1007/s11914-019-00542-w

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  47 in total

1.  Fracture Risk Assessment in Long-term Care (FRAiL): Development and Validation of a Prediction Model.

Authors:  Sarah D Berry; Andrew R Zullo; Yoojin Lee; Vincent Mor; Kevin W McConeghy; Geetanjoli Banerjee; Ralph B D'Agostino; Lori Daiello; David Dosa; Douglas P Kiel
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-05-09       Impact factor: 6.053

2.  Factors Associated With High-Quality Guidelines for the Pharmacologic Management of Chronic Diseases in Primary Care: A Systematic Review.

Authors:  Caroline de Godoi Rezende Costa Molino; Nathalia Celini Leite-Santos; Franciele Cordeiro Gabriel; Sheila Kalb Wainberg; Luciana Pereira de Vasconcelos; Rafael Augusto Mantovani-Silva; Eliane Ribeiro; Nicolina Silvana Romano-Lieber; Airton Tetelbom Stein; Daniela Oliveira de Melo
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

3.  Development of a risk assessment tool for osteoporotic fracture prevention: A claims data approach.

Authors:  Katrin C Reber; Hans-Helmut König; Clemens Becker; Kilian Rapp; Gisela Büchele; Sarah Mächler; Ivonne Lindlbauer
Journal:  Bone       Date:  2018-02-05       Impact factor: 4.398

4.  A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.

Authors:  M Yoshimura; K Moriwaki; S Noto; T Takiguchi
Journal:  Osteoporos Int       Date:  2016-10-14       Impact factor: 4.507

5.  Trends and Disparities in Osteoporosis Screening Among Women in the United States, 2008-2014.

Authors:  Catherine W Gillespie; Pamela E Morin
Journal:  Am J Med       Date:  2016-11-21       Impact factor: 4.965

6.  Recognition of vertebral fracture in a clinical setting.

Authors:  S H Gehlbach; C Bigelow; M Heimisdottir; S May; M Walker; J R Kirkwood
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

7.  Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.

Authors:  Y Su; F T T Lai; B H K Yip; J C S Leung; T C Y Kwok
Journal:  Osteoporos Int       Date:  2018-05-17       Impact factor: 4.507

8.  Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study.

Authors:  Margaret L Gourlay; Victor S Ritter; Jason P Fine; Robert A Overman; John T Schousboe; Peggy M Cawthon; Eric S Orwoll; Tuan V Nguyen; Nancy E Lane; Steven R Cummings; Deborah M Kado; Jodi A Lapidus; Susan J Diem; Kristine E Ensrud
Journal:  Arch Osteoporos       Date:  2017-10-20       Impact factor: 2.617

9.  The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study.

Authors:  David A Turner; Rebekah Fong Soe Khioe; Lee Shepstone; Elizabeth Lenaghan; Cyrus Cooper; Neil Gittoes; Nicholas C Harvey; Richard Holland; Amanda Howe; Eugene McCloskey; Terence W O'Neill; David Torgerson; Richard Fordham
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

10.  Screening for osteoporosis: A systematic assessment of the quality and content of clinical practice guidelines, using the AGREE II instrument and the IOM Standards for Trustworthy Guidelines.

Authors:  Lamia M Hayawi; Ian D Graham; Peter Tugwell; Said Yousef Abdelrazeq
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

View more
  2 in total

Review 1.  Challenges and opportunities for quality densitometry in Latin America.

Authors:  Sergio Setsuo Maeda; Ramiro Da Silva LLibre; Henrique Pierotti Arantes; Guilherme Cardenaz de Souza; Francisco Fidencio Cons Molina; Diana Wiluzanski; Jorge Antonio Cedeño Taborda; Claudia Campusano Montaño; Tatiana Maida Vargas; Guillermo Luis Feldmann Lopez; Luis Vidal Neira; Gustavo Adolfo Molina Uribe; Daniel Salica; Ascanio Rafael Bencosme; Sonia Cerdas Perez; Carlos Ramón Rios Acosta; John J Carey; João Lindolfo Cunha Borges
Journal:  Arch Osteoporos       Date:  2021-02-02       Impact factor: 2.617

2.  An update of the prevalence of osteoporosis, fracture risk factors, and medication use among community-dwelling older adults: results from the Canadian Longitudinal Study on Aging (CLSA).

Authors:  Caitlin McArthur; Ahreum Lee; Hajar Abu Alrob; Jonathan D Adachi; Lora Giangregorio; Lauren E Griffith; Suzanne Morin; Lehana Thabane; George Ioannidis; Justin Lee; William D Leslie; Alexandra Papaioannou
Journal:  Arch Osteoporos       Date:  2022-02-04       Impact factor: 2.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.